Theryte of Liverpool (WO 99/42835) describes a test to determine which
chemotherapy agent is best for treating a particular tumour: chemotherapy with
cis-platinum or taxanes such as taxol. Theryte鈥檚 trick is to fluorescently label
a tumour biopsy sample with antibodies against the telltale cyclin D1 protein.
If laser light highlights an abundance of D1, taxane treatment is recommended;
if D1 is absent, cis-platinum is prescribed. This, says Theryte, saves
money鈥攁nd lives鈥攂y quickly finding the most appropriate treatment.
More from New Scientist
Explore the latest news, articles and features
Technology
Why full-fledged quantum computers might always be five years away
Comment
Technology
Quantum computers are starting to become useful as scientific tools
News
Technology
OpenAI’s hacking agent went rogue. Should we be worried?
News
Technology
China is trying to regulate relationships with AI 鈥� can it work?
News
Popular articles
Trending New Scientist articles